Corticotropin-releasing factor-binding protein concentrations in plasma of patients with hypothalamic-pituitary-adrenal disorders.
Immunoreactive corticotropin-releasing factor-binding protein (CRF-BP) concentrations in human plasma were determined by means of radioimmunoassay for human CRF-BP. CRF-BP antiserum to the C-terminal fragment of human CRF-BP (298-322) was produced, and CRF-BP (298-322) was used as the tracer and the standard. Large amounts of human CRF did not affect measurement of plasma CRF-BP with this radioimmunoassay. The basal plasma CRF-BP concentration in normal subjects was 4.19 +/- 0.57 nmol/L (mean +/- SD). The CRF-BP concentration was low in patients with Cushing's syndrome, except those with preclinical Cushing's syndrome, and high in patients with Addison's disease, hypopituitarism and isolated ACTH deficiency. After surgery, the plasma CRF-BP concentration in patients with Cushing's syndrome rose, peaked, and then decreased to the control level. In patients with Addison's disease, the high plasma CRF-BP concentration decreased to the control level after hydrocortisone replacement, the same as plasma ACTH concentration. These findings suggest that the immunoreactive CRF-BP concentration in human plasma was decreased by glucocorticoids, at least under chronic conditions.
Ohmori
N
N
Department of Medicine, Tokyo Women's Medical College, Japan.
Suda
T
T
Sato
Y
Y
Kasagi
Y
Y
Tozawa
H
H
Dobashi
I
I
Demura
H
H
D000224:Addison Disease / Q000097:blood*; D000324:Adrenocorticotropic Hormone / Q000172:deficiency*; D000328:Adult; D002352:Carrier Proteins / Q000097:blood*; D003480:Cushing Syndrome / Q000097:blood*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007018:Hypopituitarism / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011863:Radioimmunoassay
D002352:Carrier Proteins; C067133:corticotropin releasing factor-binding protein; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone